Topic #
27 in CADD
Series
DRug
RePuRPOSI
ng wiTh
CADD
Iqra Ahmad
D r u g r e p u r p o s i n g , the
s t r a t e g y of f inding
n e w u ses for e x i s t i n g
drugs ,
is g a i n i n g m o m e n t u m
as a c o s t - effective and
t i m e - saving
a l t e rn a t i v e to
traditional drug
development.
Iqra Ahmad
Traditional drug
discovery can take over
Repurposing
a decade from concept
to approval.
Matters? Drug repurposing uses
pre- approved drugs,
avoiding early- stage
Why Drug
testing for toxicity and
safety.
CADD technologies enable
efficient library screening,
drug- target modeling,
and candidate
prioritization.
This method has already
found success inIqra Ahmad
treatments for cancer
and infectious diseases.
🔄 CADD’s Role in Drug
Repurposing
Molecular Docking
Finds binding affinities between existing drugs and new
targets.
Virtual Screening
Analyzes extensive compound libraries to identify
promising matches.
Pharmacophore Modeling
Predicts essential features for effective drug-target
interactions.
AI Algorithms
Iqra Ahmad
Analyze biological data to discover high-potential
repurposing opportunities.
Notable Successes in
CADD- Driven Drug
Repurposing
R e m d e s i v i r w a s originally
d e v e l o p e d for Ebola but
h a s shown e ff e c t i v e n e s s
against
C O V I D - 19.
T h a l i d o m i d e , initially a
s e d a t i v e , is now u s e d for
cancer and inflammatory
conditions.
Iqra Ahmad
Key Takeaway
As new diseases emerge, CADD-
powered drug repurposing offers
a powerful, efficient way to bring
therapies to patients faster.
Researchers continue to
explore how CADD can expand
the therapeutic reach of
existing drugs and redefine the
future of drug discovery.
Iqra Ahmad
Follow for more
such content
Iqra Ahmad
linkedin.com/in/iqra40902/